# Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension

> **NCT05880056** · PHASE4 · RECRUITING · sponsor: **Genuine Research Center, Egypt** · enrollment: 406 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Nerkardou (5 mg) & (10 mg)

## Key facts

- **NCT ID:** NCT05880056
- **Lead sponsor:** Genuine Research Center, Egypt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-08
- **Primary completion:** 2025-04-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 406 (ESTIMATED)
- **Last updated:** 2024-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05880056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05880056, "Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05880056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*